ArticleMolecular cancer2024

Loss of the tumour suppressor LKB1/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy.

Andriani Angelopoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.